BL-M09D1

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BL-M09D1, covering 2025-05-31 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors [Phase 1]

See pricing